Methods for risk assessment, survival prediction and treatment of heart failure and other conditions based on adrenergic receptor polymorphisms

Details for Australian Patent Application No. 2004272102 (hide)

Owner University Of Cincinnati

Inventors Liggett, Stephen Bryant; Wagoner, Lynne Elizabeth

Agent FB Rice

Pub. Number AU-A-2004272102

PCT Pub. Number WO2005/025409

Priority 60/502,837 12.09.03 US

Filing date 13 September 2004

Wipo publication date 24 March 2005

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

13 April 2006 PCT application entered the National Phase

  PCT publication WO2005/025409 Priority application(s): WO2005/025409

5 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004272104-Fused ring heterocycles as potassium channel modulators

2004272098-Oleamide-containing composition for animal consumption